InsidersTradesSigma
Explore the detailed record of transactions filed by McHale Duncan, Directeur. Insider active across 1 companies, notably Evelo Biosciences, Inc.. Cumulatively, 1 disclosures have been recorded. Total volume traded: €47k. The latest transaction was filed on 27 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Duncan McHale is the Chief Medical Officer at Evelo Biosciences, Inc. In this role, he oversees the medical and scientific aspects of the company's operations. His expertise in biology and medicine enables him to guide the development of new therapies and ensure their compliance with regulatory standards.